Evidence map›Paper›PMID 41134425›Full record

SynthesisDigestive diseases and sciences2026

Prophylactic Antibiotics Reduce Infectious Complications After ERCP in Patients with Suspected Biliary Obstruction: A Meta-Analysis of Randomized Controlled Trials.

Toni Habib, Chloe Lahoud, Elie Moussa, Bruno Habib, Brendan Plann-Curley, Hassan Al Moussawi, Youssef El Douaihy, Sherif Andrawes, Vishnu Kumar, Jorge D Machicado and 1 more

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Toni HabibDepartment of Internal Medicine, Staten Island University Hospital, Northwell Health, 475 Seaview Avenue, Staten Island, NY, USA.
Chloe LahoudDepartment of Internal Medicine, Staten Island University Hospital, Northwell Health, 475 Seaview Avenue, Staten Island, NY, USA.
Elie MoussaDepartment of Internal Medicine, Staten Island University Hospital, Northwell Health, 475 Seaview Avenue, Staten Island, NY, USA.
Bruno HabibFaculty of Medicine, Université Catholique de Louvain, 1200, Woluwe-Saint-Lambert, Belgium.
Brendan Plann-CurleyNorthwell Health Medical Libraries, Staten Island University Hospital, Staten Island, NY, USA.
Hassan Al MoussawiDivision of Gastroenterology & Hepatology, Department of Internal Medicine, Staten Island University Hospital, Northwell Health, Staten Island, NY, 10305, USA.
Youssef El DouaihyDivision of Gastroenterology & Hepatology, Department of Internal Medicine, Staten Island University Hospital, Northwell Health, Staten Island, NY, 10305, USA.
Sherif AndrawesDivision of Gastroenterology & Hepatology, Department of Internal Medicine, Staten Island University Hospital, Northwell Health, Staten Island, NY, 10305, USA.
Vishnu KumarDivision of Gastroenterology & Hepatology, Department of Internal Medicine, Staten Island University Hospital, Northwell Health, Staten Island, NY, 10305, USA.
Jorge D MachicadoDivision of Gastroenterology, University of Michigan, Ann Arbor, MI, USA.
Jean M ChalhoubDivision of Gastroenterology & Hepatology, Department of Internal Medicine, Staten Island University Hospital, Northwell Health, Staten Island, NY, 10305, USA. jchalhoub@northwell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsProphylactic antibiotic use before endoscopic retrograde cholangiopancreatography (ERCP) remains controversial. Current guidelines recommend against routine prophylaxis. This meta-analysis evaluates the role of prophylactic antibiotics in reducing infectious complications in patients with suspected biliary obstruction undergoing ERCP.

methodsWe included randomized controlled trials (RCTs) published in full and comparing antibiotics with placebo in patients undergoing ERCP for suspected biliary obstruction. Outcomes assessed were rates of cholangitis, bacteremia, and infectious complications. Data sources included CENTRAL, MEDLINE, and EMBASE from inception through January 2025. Studies published as abstract only were excluded. For subgroup analyses, studies were stratified by antibiotic class (cephalosporins vs penicillins), presence of radiologic evidence or clinical suspicion of obstruction, and sample size (n <150 vs n ≥ 150).

results5 RCTs involving 1,154 patients met inclusion criteria, with 570 individuals receiving antibiotics and 584 serving as controls. Prophylactic antibiotics significantly reduced the risk of cholangitis (RR 0.44, 95% CI 0.22-0.89, p = 0.24; I

conclusionProphylactic antibiotics significantly reduced post-ERCP infections in patients with biliary obstruction. These findings challenge existing guidelines that recommend antibiotics in high-risk scenarios only. Our study highlights the importance of pre-procedural antibiotics, especially in patients with radiologically confirmed biliary obstruction. While further RCTs are needed to refine recommendations, clinicians should consider prophylactic antibiotics to improve patient outcomes.

Indexed as

Anti-Bacterial AgentsAntibiotic ProphylaxisBacteremiaCholangiopancreatography, Endoscopic RetrogradeCholangitisCholestasisHumansRandomized Controlled Trials as TopicAnti-Bacterial AgentsAntibioticsBacteremiaCholangitisERCPInfectious complicationsProphylaxis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.